Amy Sprague, MD
Nephrology · Georgetown, SCNPI 1629030598
Payments from drug & device makers
Across 166 payments — averaging $9137.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$722K
- Eli Lilly$551K
- Astrazeneca UK Limited$70K
- Pfizer$50K
- AbbVie$24K
- AstraZeneca$24K
- plus $75K from 17 others
Across 13 payments — averaging $1692.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$21K
- AbbVie$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 77 | $722,103 |
| Eli Lilly | 14 | $551,232 |
| Astrazeneca UK Limited | 1 | $70,454 |
| Pfizer | 11 | $50,409 |
| AbbVie | 9 | $24,133 |
| AstraZeneca | 1 | $23,500 |
| Janssen Research & Development, LLC | 4 | $20,885 |
| GSK | 10 | $17,764 |
| Boehringer Ingelheim | 1 | $15,400 |
| Akebia Therapeutics Inc | 12 | $12,273 |
| Outset Medical Inc | 1 | $7,130 |
| Boehringer Ingelheim International GmbH | 12 | $672 |
| Merck | 2 | $169 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Portola Pharmaceuticals, LLC | 1 | $122 |
| Acelrx Pharmaceuticals, Inc. | 1 | $101 |
| Astellas Pharma US Inc | 1 | $97 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $90 |
| Nxstage Medical, Inc. | 1 | $66 |
| Baxter Healthcare | 1 | $57 |
| Sanofi | 1 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Stryker | 1 | $29 |
How this compares
$1,516,879 in reported general payments places this provider in the 95th percentile of 180 nephrology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Georgetown
- Barry GorlitskyGreenville$3.1M
- Moustafa MoustafaOrangeburg$3M
- Pusadee SuchindaSumter$1.3M
- Jessica ColemanBeaufort$930K
- Asha BaileyColumbia$724K
- Thomas PowellColumbia$704K
- Roberto PisoniCharleston$512K
- Harold SzerlipCharleston$443K
- Howard LiflandColumbia$261K
- Blaithin McMahonCharleston$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.